Exalenz Bioscience

Exalenz Bioscience Ltd. develops and commercializes advanced systems, with its BreathID technology platform capable of extracting vital diagnostic information from subtle changes in a patient's exhaled breath. These products can enhance the quality of patient care, improve the efficiency of clinics and medical centers, and increase revenue.Exalenz Bioscience's proprietary core technology enables healthcare professionals to identify and manage specific digestive and liver conditions with unprecedented ease, patient comfort, and clinical precision.The BreathID technology platform addresses the long-standing need for rapid, convenient, and accurate assessment and monitoring of liver and gastrointestinal functional disorders in medical institutions. It continuously, automatically, and in real-time measures minute changes in the parts-per-million ratio of 13C/12C molecules in a patient’s exhaled breath. Designed for mobility and user-friendly operation, BreathID products can be used in offices or clinics.